For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
According to our (Global Info Research) latest study, the global Oxaliplatin market size was valued at USD 923.5 million in 2022 and is forecast to a readjusted size of USD 1636.5 million by 2029 with a CAGR of 8.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
This report is a detailed and comprehensive analysis for global Oxaliplatin market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oxaliplatin market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oxaliplatin market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oxaliplatin market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oxaliplatin market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oxaliplatin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oxaliplatin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical and Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oxaliplatin market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Mannitol
- Glucose Solution
- Lactose Solution
- Others
Market segment by Application
- Colorectal Cancer
- Stomach Cancer
- Ovarian Cancer
- Others
Market segment by players, this report covers
- Sanofi-Aventis
- Yakult honsha
- Dr Reddy's laboratories
- Sun Pharmaceutical
- Teva
- Fresenius Kabi
- Hospira
- Mylan
- Jiangsu Hengrui Medicine
- Nanjing Pharmaceutical Factory
- Jiangsu Aosaikang Pharmaceutical
- Qilu Pharmaceutical
- Hisun Pharmaceutical
- Lunan Pharmaceutical
- Luoxin
- Halfsky Pharmacy
- YRPG
- Hainan Jinrui Pharmaceutical
- Jari Pharmaceutical
- Chiatai Tianqing
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oxaliplatin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oxaliplatin, with revenue, gross margin and global market share of Oxaliplatin from 2018 to 2023.
Chapter 3, the Oxaliplatin competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oxaliplatin market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oxaliplatin.
Chapter 13, to describe Oxaliplatin research findings and conclusion.